Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core transcriptional regulatory circuitry (CRC) consists of autoregulated transcription factors (TFs) and their enhancers, which dominate gene expression programs and control cell fate. However, there is limited knowledge of CRC in TNBC. Herein, we systemically characterized the activated super-enhancers (SEs) and interrogated 14 CRCs in breast cancer. We found that CRCs could be broadly involved in DNA conformation change, metabolism process, and signaling response affecting the gene expression reprogramming. Furthermore, these CRC TFs are capable of coordinating with partner TFs bridging the enhancer-promoter loops. Notably, the CRC TF and partner pa...
Cancer cells frequently feature aberrant transcriptional program that sustain their oncogenic featur...
Gene expression programmes driving cell identity are established by tightly regulated transcription ...
Different breast cancer (BC) subtypes have unique gene expression patterns, but their regulatory mec...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
A core transcriptional regulatory circuit (CRC) is a group of interconnected auto-regulating transcr...
Triple Negative Breast Cancer (TNBC) is a heterogeneous disease lacking known molecular drivers and ...
Gene expression programmes driving cell identity are established by tightly regulated transcription ...
Breast cancer is a highly heterogeneous disease with differences in histopathological and biological...
Cancer cells frequently feature aberrant transcriptional program that sustain their oncogenic featur...
Gene expression programmes driving cell identity are established by tightly regulated transcription ...
Different breast cancer (BC) subtypes have unique gene expression patterns, but their regulatory mec...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core trans...
A core transcriptional regulatory circuit (CRC) is a group of interconnected auto-regulating transcr...
Triple Negative Breast Cancer (TNBC) is a heterogeneous disease lacking known molecular drivers and ...
Gene expression programmes driving cell identity are established by tightly regulated transcription ...
Breast cancer is a highly heterogeneous disease with differences in histopathological and biological...
Cancer cells frequently feature aberrant transcriptional program that sustain their oncogenic featur...
Gene expression programmes driving cell identity are established by tightly regulated transcription ...
Different breast cancer (BC) subtypes have unique gene expression patterns, but their regulatory mec...